Artios Banks $153m On The Back Of Novartis And Merck KGaA Deals
UK Biotech Completes Impressive Series C
Artios Pharma rides the wave of DDR enthusiasm following the recent signing of big pharma partnerships with a financing to bring its first-in-class cancer treatments into the clinic.
